BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang XL, Zhang XW, Wang TY, Wang HW, Chen Z, Xu B, Xu W. Off-Label Under- and Overdosing of Direct Oral Anticoagulants in Patients With Atrial Fibrillation: A Meta-Analysis. Circ Cardiovasc Qual Outcomes 2021;14:e007971. [PMID: 34932377 DOI: 10.1161/CIRCOUTCOMES.121.007971] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Kubota K, Ooba N. Effectiveness and Safety of Reduced and Standard Daily Doses of Direct Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation: A Cohort Study Using National Database Representing the Japanese Population. CLEP 2022;Volume 14:623-39. [DOI: 10.2147/clep.s358277] [Reference Citation Analysis]
2 Burnett AE, Barnes GD. A call to action for anticoagulation stewardship. Res Pract Thromb Haemost 2022;6:e12757. [PMID: 35865732 DOI: 10.1002/rth2.12757] [Reference Citation Analysis]
3 Miyazaki S, Miyauchi K, Hayashi H, Yamashiro K, Tanaka R, Nishizaki Y, Nojiri S, Suwa S, Sumiyoshi M, Nakazato Y, Urabe T, Hattori N, Minamino T, Daida H. Trends of anticoagulant use and outcomes of patients with non-valvular atrial fibrillation: Findings from the RAFFINE registry. Journal of Cardiology 2022. [DOI: 10.1016/j.jjcc.2022.03.006] [Reference Citation Analysis]
4 Shurrab M, Ryu R, Jackevicius CA. Off-Label Direct Oral Anticoagulant Dosing: Caution Advised. Circ Cardiovasc Qual Outcomes 2021;14:e008608. [PMID: 34932378 DOI: 10.1161/CIRCOUTCOMES.121.008608] [Reference Citation Analysis]
5 de Vries TAC, Hirsh J, Chan NC. Letter by de Vries et al Regarding Article "Off-Label Under- and Overdosing of Direct Oral Anticoagulants in Patients With Atrial Fibrillation: A Meta-Analysis". Circ Cardiovasc Qual Outcomes 2022;15:e008982. [PMID: 35477257 DOI: 10.1161/CIRCOUTCOMES.122.008982] [Reference Citation Analysis]
6 Ryu R, Tran R. DOACs in Mechanical and Bioprosthetic Heart Valves: A Narrative Review of Emerging Data and Future Directions. Clin Appl Thromb Hemost 2022;28:10760296221103578. [PMID: 35642259 DOI: 10.1177/10760296221103578] [Reference Citation Analysis]
7 Giugliano RP. Non-vitamin K antagonist oral anticoagulants in older and frail patients with atrial fibrillation. European Heart Journal Supplements 2022;24:A1-A10. [DOI: 10.1093/eurheartj/suab150] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Zhang XL, Wang HW, Xu B, Xu W. Response by Zhang et al Regarding Article "Off-Label Under- and Overdosing of Direct Oral Anticoagulants in Patients With Atrial Fibrillation: A Meta-Analysis". Circ Cardiovasc Qual Outcomes 2022;15:e009065. [PMID: 35477259 DOI: 10.1161/CIRCOUTCOMES.122.009065] [Reference Citation Analysis]